Top compounds associated with response to CLPTM1L


Feature Type Standardized
Nominal ANOVA
mRNA ML258 CTRPv2 pan-cancer AAC 0.069 0.07
mRNA Camptothecin GDSC1000 pan-cancer AAC -0.063 0.07
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.054 0.07
mRNA PF-573228 CTRPv2 pan-cancer AAC -0.062 0.07
mRNA regorafenib CTRPv2 pan-cancer AAC -0.068 0.07
mRNA Bortezomib CTRPv2 pan-cancer AAC 0.063 0.07
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.058 0.07
mRNA AP-24534 GDSC1000 pan-cancer AAC -0.062 0.07
mRNA TG-101348 GDSC1000 pan-cancer AAC -0.052 0.08
mRNA Bortezomib gCSI pan-cancer AAC 0.1 0.08
Download CSV